Jurcic, J G <br/><br/>
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.  [electronic resource] 

 -  Leukemia  Feb 1995 
 - 244-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, Myelomonocytic--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Cell Differentiation--drug effects<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Idarubicin--administration & dosage<br/>Immunologic Factors--therapeutic use<br/>Leukemia, Promyelocytic, Acute--mortality<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins<br/>Neoplasm, Residual<br/>Neutropenia--etiology<br/>Nuclear Proteins<br/>Oncogene Proteins, Fusion--analysis<br/>Polymerase Chain Reaction<br/>Promyelocytic Leukemia Protein<br/>Receptors, Retinoic Acid--analysis<br/>Remission Induction<br/>Salvage Therapy<br/>Sialic Acid Binding Ig-like Lectin 3<br/>Survival Analysis<br/>Transcription Factors--analysis<br/>Treatment Outcome<br/>Tretinoin--pharmacology<br/>Tumor Suppressor Proteins